We have found 46590 results matching your criteria.
Please wait while we search...
  1. 1.
    General Material Information
  2. 2.
    PhysChem Properties
  3. 3.
    Occurrences
  4. 4.
    Organoleptic Properties
  5. 5.
    Suppliers
  6. 6.
    Potential Uses
  7. 7.
    Regulatory & Documentation
  8. 8.
    Safety Information
  9. 9.
    Other Information
  10. 10.
    Blenders & Components
  11. 11.
    Literature & References

vaccinium vitis-idaea fruit extract

Vaccinium vitis-idaea fruit extract is a natural substance obtained from lingonberry fruits, noted for its berry flavor and used primarily as a nutrient supplement.

General Material Description

Vaccinium vitis-idaea fruit extract is derived from the fruit of the cowberry plant, Vaccinium vitis-idaea L., which belongs to the Ericaceae family. This extract is a natural botanical ingredient recognized for its characteristic berry flavor, primarily describing lingonberries. Known also by synonyms such as cowberry fruit extract and lingonberry fruit extract, it appears as a natural compound used in nutrient adjuncts and dietary supplements. The chemical composition links to documented profiles available on PubChem, providing standardized reference data. The extract is obtained through processes that concentrate constituents from lingonberry fruits, which are widespread in northern temperate regions. It is valued for its natural origin and flavor profile in nutritional applications.

Occurrence, Applicability & Potential Uses

Vaccinium vitis-idaea fruit extract naturally occurs in the fruit of the lingonberry plant, common in boreal forests and tundra environments. Its biological role includes plant defense and attractant functions. The extract finds application in dietary supplements serving as nutrient adjuncts and nutrient agents. It is also explored in cosmetic formulations for antioxidant properties. Usage recommendations found in REACH (EU) registrations address regulatory compliance for botanical extracts. The extract is not intended for fragrance or flavor use in formulations but supports health-related products through its botanical origin and bioactive constituents.

Physico-Chemical Properties Summary

The extract exhibits typical properties of berry-derived botanical concentrates, including solubility in aqueous and hydroalcoholic media, a characteristic berry aroma, and a specific color profile derived from natural pigments. These chemical and physical features influence its behavior in formulations, ensuring compatibility with dietary supplement matrices. Its stable nature at ambient temperatures supports shelf life requirements. The molecular complexity combines flavonoids, phenolic acids, and other natural compounds. These constituents collectively define the sensory and functional profile, facilitating applications as nutrient adjuncts without flavoring intent.

FAQ

What is Vaccinium vitis-idaea fruit extract and what are its main characteristics?
Vaccinium vitis-idaea fruit extract is obtained from the fruit of the lingonberry plant, a species within the Ericaceae family. Known also as cowberry extract, it is characterized by a distinctive berry aroma typical of lingonberries. The extract contains natural compounds like flavonoids and phenolics, contributing to its sensory and functional properties. It is primarily used in dietary supplements and nutrient adjuncts, drawing on its botanical origin and characteristic flavor profile.
How is Vaccinium vitis-idaea fruit extract used and where does it come from?
This extract is derived from the lingonberry fruit, which grows in northern temperate climates, including boreal forests. It is applied mainly as a nutrient adjunct and dietary supplement ingredient, leveraging its natural composition without use for fragrance or flavoring. Its antioxidant content supports applications in cosmetic products as well. The processing concentrates bioactive constituents from the raw fruit to produce a stable, standardized extract suitable for various nutritional formulations.
Are there regulations or safety considerations for using Vaccinium vitis-idaea fruit extract?
Vaccinium vitis-idaea fruit extract is registered under REACH (EU) regulations, ensuring compliance with chemical safety standards in Europe. Available safety data indicate no classified hazards according to OSHA HCS (US), and no specific precautionary statements are assigned. Usage guidelines advise against its use as a fragrance or flavor ingredient, specifying applications limited to nutrient adjuncts and dietary supplements. Relevant toxicology and exposure information is accessible through EPA and FDA databases, providing further regulatory context.

US / EU / FDA / JECFA / FEMA / Scholar / Patents

Google Scholar Start search
Google Books Start search
Google Patents Start search
Perfumer & Flavorists Start search
EU Patents Start search
PubMeb Start search
NCBI Start search

Literature & References

vaccinium vitis-idaea l. fruit extract
Pubchem (sid):135300928
Publications by PubMed
Blueberry (Vaccinium corymbosum L.).
Role of a prudent breakfast in improving cardiometabolic risk factors in subjects with hypercholesterolemia: A randomized controlled trial.
In vitro inhibitory effect on digestive enzymes and antioxidant potential of commonly consumed fruits.
In vitro antiviral activity of a series of wild berry fruit extracts against representatives of Picorna-, Orthomyxo- and Paramyxoviridae.
The antioxidant level of Alaska's wild berries: high, higher and highest.
Prevention of urinary tract infections with vaccinium products.
Chemical analysis and effect of blueberry and lingonberry fruits and leaves against glutamate-mediated excitotoxicity.
Biological availability of (238)U, (234)U and (226)Ra for wild berries and meadow grasses in natural ecosystems of Belarus.
1H NMR-based metabolic fingerprinting of urine metabolites after consumption of lingonberries (Vaccinium vitis-idaea) with a high-fat meal.
Berries reduce postprandial insulin responses to wheat and rye breads in healthy women.
Micropropagation of Vaccinium sp. by in vitro axillary shoot proliferation.
HPLC-MSn identification and quantification of flavonol glycosides in 28 wild and cultivated berry species.
Children's hedonic response to berry products: Effect of chemical composition of berries and hTAS2R38 genotype on liking.
Enhanced UV-B and elevated CO(2) impacts sub-arctic shrub berry abundance, quality and seed germination.
Comparing procyanidins in selected Vaccinium species by UHPLC-MS(2) with regard to authenticity and health effects.
Composition of sugars, organic acids, and total phenolics in 25 wild or cultivated berry species.
Postprandial glucose, insulin, and free fatty acid responses to sucrose consumed with blackcurrants and lingonberries in healthy women.
Purification of berry flavonol glycosides by long-bed gel permeation chromatography.
Comparison of the triterpenoid content of berries and leaves of lingonberry Vaccinium vitis-idaea from Finland and Poland.
Comparisons of large (Vaccinium macrocarpon Ait.) and small (Vaccinium oxycoccos L., Vaccinium vitis-idaea L.) cranberry in British Columbia by phytochemical determination, antioxidant potential, and metabolomic profiling with chemometric analysis.
Fruit juice-induced endothelium-dependent relaxations in isolated porcine coronary arteries: evaluation of different fruit juices and purees and optimization of a red fruit juice blend.
Phenolic compounds in berries and flowers of a natural hybrid between bilberry and lingonberry (Vaccinium × intermedium Ruthe).
Food grade lingonberry extract: polyphenolic composition and in vivo protective effect against oxidative stress.
Lingonberry (Vaccinium vitis-idaea) and European cranberry (Vaccinium microcarpon) proanthocyanidins: isolation, identification, and bioactivities.
Ursolic acid and its esters: occurrence in cranberries and other Vaccinium fruit and effects on matrix metalloproteinase activity in DU145 prostate tumor cells.
Antiaggregation potential of berry fractions against pairs of Streptococcus mutans with Fusobacterium nucleatum or Actinomyces naeslundii.
Genus vaccinium: medicine, cosmetics, and coatings.
Stimulation of AMP-activated protein kinase and enhancement of basal glucose uptake in muscle cells by quercetin and quercetin glycosides, active principles of the antidiabetic medicinal plant Vaccinium vitis-idaea.
Bioavailability of various polyphenols from a diet containing moderate amounts of berries.
Inhibitory effect of the Cree traditional medicine wiishichimanaanh (Vaccinium vitis-idaea) on advanced glycation endproduct formation: identification of active principles.
Distribution of 210Pb and 210Po concentrations in wild berries and mushrooms in boreal forest ecosystems.
Effects of a warmer climate on seed germination in the subarctic.
Urinary excretion of the main anthocyanin in lingonberry (Vaccinium vitis-idaea), cyanidin 3-O-galactoside, and its metabolites.
Binding of Neisseria meningitidis pili to berry polyphenolic fractions.
Metabolism of berry anthocyanins to phenolic acids in humans.
Berries as chemopreventive dietary constituents--a mechanistic approach with the ApcMin/+ mouse.
Berry extracts exert different antiproliferative effects against cervical and colon cancer cells grown in vitro.
Berry fruits: compositional elements, biochemical activities, and the impact of their intake on human health, performance, and disease.
Rapid screening of anthocyanins in berry samples by surfactant-mediated matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Anthocyanin- and proanthocyanidin-rich extracts of berries in food supplements--analysis with problems.
Three Nordic berries inhibit intestinal tumorigenesis in multiple intestinal neoplasia/+ mice by modulating beta-catenin signaling in the tumor and transcription in the mucosa.
Berry phenolic extracts modulate the expression of p21(WAF1) and Bax but not Bcl-2 in HT-29 colon cancer cells.
Characterization of phenolic compounds from lingonberry (Vaccinium vitis-idaea).
Berry phenolics: antimicrobial properties and mechanisms of action against severe human pathogens.
Bioavailability of quercetin from berries and the diet.
Cutin composition of five finnish berries.
Antioxidant capacity and phenolic content of sweet rowanberries.
Catechins and procyanidins in berries of vaccinium species and their antioxidant activity.
Characterization of phenolic profiles of Northern European berries by capillary electrophoresis and determination of their antioxidant activity.
Antioxidant activity in lingonberries (Vaccinium vitis-idaea L.) and its inhibitory effect on activator protein-1, nuclear factor-kappaB, and mitogen-activated protein kinases activation.
Berry phenolics selectively inhibit the growth of intestinal pathogens.
Total oxidant scavenging capacities of common European fruit and vegetable juices.
Inhibition of protein and lipid oxidation in liposomes by berry phenolics.
Resveratrol, pterostilbene, and piceatannol in vaccinium berries.
Stability and enhancement of berry juice color.
Allergy to lingonberry: A case report.
Cranberries for preventing urinary tract infections.
[Complex approach to evaluation of natural quality of coloured juices].
Oxygen radical absorbing capacity of phenolics in blueberries, cranberries, chokeberries, and lingonberries.
Randomised trial of cranberry-lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women.
Influence of domestic processing and storage on flavonol contents in berries.
Content of the flavonols quercetin, myricetin, and kaempferol in 25 edible berries.
In vitro anticancer activity of fruit extracts from Vaccinium species.
Metals in Finnish liqueurs.
[Contents of manganese and vitamin C in the fruits of bilberriers and red berries (Vaccinium myrtillus L.) and red berries (Vaccinium vitis-idaea L.) growing in highly industrialized areas].
The aroma of cranberries. 3. Juice of Vaccinium vitis-idaea L.
[Wormicide activity of extracts from the dry fruit of black bilberries (Vaccinium myrtillus l.), red bilberries (Vaccinium vitis idaea L.) and marsh cranberries (Oxycoccus quadripetalus Gilib.) on (Enchytraeus albidus)].

Other Information

FDA Listing of Food Additive Status:View
Wikipedia:View

General Material Information

Preferred name vaccinium vitis-idaea fruit extract
Trivial Name Vaccinium vitis-idaea, ext.
Short Description extract of the fruit of the cowberry, vaccinium vitis-idaea l., ericaceae
CAS Number 90131-85-4
ECHA Number 290-400-3
FDA UNII Search
Synonyms
  • cowberry fruit extract
  • extract of the fruit of the cowberry, vaccinium vitis-idaea l., ericaceae
  • lingonberry fruit extract
  • rhodococcum vitis-idaea fruit extract
  • vaccinium jesoense fruit extract
  • vaccinium vitis-idaea l. fruit extract
  • Vaccinium vitis-idaea, ext.

PhysChem Properties

Material listed in food chemical codex No

Organoleptic Properties

Flavor Type: Berry
lingonberry
General comment Lingonberry

Occurrences

Safety Information

Safety information

Hazards identification
Classification of the substance or mixture
GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)
None found.
GHS Label elements, including precautionary statements
Pictogram
Hazard statement(s)
None found.
Precautionary statement(s)
None found.
Oral/Parenteral Toxicity:
Not determined
Dermal Toxicity:
Not determined
Inhalation Toxicity:
Not determined

Safety in use information

Category:
nutrient adjuncts, dietary supplements, nutrient agents
Recommendation for vaccinium vitis-idaea fruit extract usage levels up to:
not for fragrance use.
Recommendation for vaccinium vitis-idaea fruit extract flavor usage levels up to:
not for flavor use.

Safety references

AIDS Citations:Search
Cancer Citations:Search
Toxicology Citations:Search
EPA ACToR:Toxicology Data
EPA Substance Registry Services (SRS):Registry
National Institute of Allergy and Infectious Diseases:Data
vaccinium vitis-idaea l. fruit extract
Chemidplus:0090131854